A small subgroup of atopic dermatitis (AD) patients, suffer from life-threatening disseminated herpes simplex virus (HSV) skin infections, termed eczema herpeticum (ADEH+). The manifestation of ADEH+ is not simply a consequence of HSV-1 infection, as latent infection of both the AD and general population is near universal (90%). Most importantly, there is a remarkable bimodality in the `recurrence' of EH episodes; most individuals have only a single episode, but a subgroup of ADEH+ have more than five (5+) lifetime episodes. Based on this, we hypothesize recurrent ADEH+ is characterized by unique: (1) genetic profiles, (2) dysregulated skin tissue transcriptional signatures, and (3) skin cell responses to HSV-1 infection, which collectively underlie ADEH+ disease development. We suggest these profiles, signatures, and responses will be most pronounced among AD patients with 5+ EH episodes as they represent the extreme of AD severity. Therefore we propose an extreme trait study, investigating recurrent ADEH+ (5+ episodes) vs. ADEH-, using genetic, transcriptomic, and cellular function analyses.
The specific aims will be: 1) To use whole genome sequencing (WGS) to identify rare deleterious genetic variants that determine recurrent ADEH+. Deep WGS data will be generated on 50 ADEH+ subjects with >5 EH episodes. We will leverage the ADRN DNA repository and expertise on WGS data from 500 ADEH- individuals through our ongoing ADRN protocol on S. aureus colonization as a control group; 2) To identify differences in the transcriptional signatures of recurrent ADEH+ vs. ADEH- in disease-relevant tissue and cells under baseline and HSV-1 stimulated conditions. We will isolate dermal and epidermal tissue from uninvolved skin biopsies of recurrent ADEH+ versus ADEH- subjects. We will also isolate plasmacytoid dendritic cells from the peripheral blood of these subjects. Paired tissues and cells from these subjects will be sham- and HSV-1-infected. Whole transcriptome RNA-sequencing (RNA-seq) will be performed on these samples. We will determine tissue/cell specific genes regulated by HSV-1 infection and whether this regulation differs by ADEH status. Differential and allele-specific expression data will be used to filter Aim 1 risk variants; 3) Compare primary cell responses to HSV-1 infection between recurrent ADEH+ vs. ADEH- and determine biological function of risk genes and genetic variants identified from WGS and RNA-seq analyses. We will culture skin primary keratinocytes and fibroblasts from the same subjects examined in Aims 1 and 2. Part 1: Paired sham and HSV-1 infected cultures will be analyzed to determine differences in the infection rates and anti-viral, inflammatory, and differentiation responses between ADEH+ and ADEH- subjects. Part 2: We will functionally characterize the effect of genes and genetic risk variants (identified in Aims 1 and 2) on these cellular HSV-1 responses by a suite of genetic modification techniques applied to these primary cells, including CRISPR/Cas9 mediated gene-editing. Our novel, integrated, multi-disciplinary extreme trait design will allow a powerful examination of the etiology of ADEH+.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-ZL-I (J1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
National Jewish Health
United States
Zip Code
Williams, Michael R; Nakatsuji, Teruaki; Sanford, James A et al. (2017) Staphylococcus aureus Induces Increased Serine Protease Activity in Keratinocytes. J Invest Dermatol 137:377-384
Nakatsuji, Teruaki; Chen, Tiffany H; Narala, Saisindhu et al. (2017) Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med 9:
Liu, Haiyun; Archer, Nathan K; Dillen, Carly A et al. (2017) Staphylococcus aureus Epicutaneous Exposure Drives Skin Inflammation via IL-36-Mediated T Cell Responses. Cell Host Microbe 22:653-666.e5
Oyoshi, Michiko K; Venturelli, Nicholas; Geha, Raif S (2016) Thymic stromal lymphopoietin and IL-33 promote skin inflammation and vaccinia virus replication in a mouse model of atopic dermatitis. J Allergy Clin Immunol 138:283-6
Shi, Baochen; Bangayan, Nathanael J; Curd, Emily et al. (2016) The skin microbiome is different in pediatric versus adult atopic dermatitis. J Allergy Clin Immunol 138:1233-1236
Leung, Donald Y M (2016) Clinical implications of new mechanistic insights into atopic dermatitis. Curr Opin Pediatr 28:456-62
Galand, Claire; Leyva-Castillo, Juan Manuel; Yoon, Juhan et al. (2016) IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells. J Allergy Clin Immunol 138:1356-1366
Malhotra, Nidhi; Yoon, Juhan; Leyva-Castillo, Juan Manuel et al. (2016) IL-22 derived from ?? T cells restricts Staphylococcus aureus infection of mechanically injured skin. J Allergy Clin Immunol 138:1098-1107.e3
Gallo, Richard L; Hultsch, Thomas; Farnaes, Lauge (2016) Recognizing that the microbiome is part of the human immune system will advance treatment of both cancer and infections. J Am Acad Dermatol 74:772-4
Li, Shan; Ganguli-Indra, Gitali; Indra, Arup K (2016) Lipidomic analysis of epidermal lipids: a tool to predict progression of inflammatory skin disease in humans. Expert Rev Proteomics 13:451-6

Showing the most recent 10 out of 24 publications